The major conclusion from the present study is that human pancreatic cancer cells undergo profound metabolic reprogramming that drives the acquisition of stem cell-like properties at different degrees after adaptation to silencing of AKT isoforms. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.